Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Prof Steyn to receive Jan H Marais Prize in Stellenbosch
2017-05-09

Description: Prof Jaap Steyn  Tags: Prof Jaap Steyn

Prof Jaap Steyn, who started his career as
journalist at Volksblad, later entered the academy,
and was a professor at the University of the
Free State for many years.
Photo: Marthie Kemp

Although Prof Jaap Steyn will be honoured officially for his contribution to Afrikaans as an academic language at the end of this month, he only became aware of his nomination after he had won the award.

According to this research fellow in the Department of Afrikaans and Dutch, German and French at the University of the Free State (UFS), he is grateful for the recognition. He has recently been awarded the Jan H Marais Prize for his outstanding contribution to Afrikaans.

Former Kovsie honoured together with Prof Jan van der Watt
According to a statement by the South African Academy for Science and Arts, the award was jointly made to Prof Steyn, who is probably the best-known South African language historian, and Prof Jan van der Watt van Nijmegen from the Netherlands. The prize money of R500 000, which they will share, will be presented in Stellenbosch on 30 May 2017.

Prof Steyn is a former Kovsie, who was a research professor at the UFS from 1985 to 1997, and at the age of 78 is still a research fellow. “After the announcement of the prize, I learnt that I was nominated by two of my colleagues,” he says.

His most difficult work was probably also his best

Over the past 50 years several of his publications, biographies, and books have seen the light. He believes that nothing one does is perfect. His most difficult work was the biography of NP van Wyk Louw. “It was probably also my best work,” he says. “The book I enjoyed working on most, was the biography of the author MER, or ME Rothmann.”

Prof Steyn has also received awards such as the Stals Prize, the Louis Hiemstra Prize, the NP van Wyk Louw medal, and honorary membership from the South African Academy for Science and Arts.

He says the staff in the Department of Afrikaans and Dutch, German and French are very friendly and helpful to still render him assistance as a research fellow.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept